Drugmaker Refuses FDA’s Request to Pull Gene Therapy Tied to Patient Deaths

(MedPage Today) — Sarepta Therapeutics will continue to ship its gene therapy delandistrogene moxeparvovec (Elevidys) to ambulant patients with Duchenne muscular dystrophy, despite the FDA’s request to halt distribution, the company stated late…